Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.jconrel.2013.11.007
DC Field | Value | |
---|---|---|
dc.title | Delivery of basic fibroblast growth factors from heparinized decellularized adipose tissue stimulates potent de novo adipogenesis | |
dc.contributor.author | Lu, Q. | |
dc.contributor.author | Li, M. | |
dc.contributor.author | Zou, Y. | |
dc.contributor.author | Cao, T. | |
dc.date.accessioned | 2014-09-18T09:22:20Z | |
dc.date.available | 2014-09-18T09:22:20Z | |
dc.date.issued | 2014-01-28 | |
dc.identifier.citation | Lu, Q., Li, M., Zou, Y., Cao, T. (2014-01-28). Delivery of basic fibroblast growth factors from heparinized decellularized adipose tissue stimulates potent de novo adipogenesis. Journal of Controlled Release 174 (1) : 43-50. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jconrel.2013.11.007 | |
dc.identifier.issn | 01683659 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/79880 | |
dc.description.abstract | Scaffolds based on decellularized adipose tissue (DAT) are gaining popularity in adipose tissue engineering due to their high biocompatibility and adipogenic inductive property. However, previous studies involving DAT-derived scaffolds have not fully revealed their potentials for in vivo adipose tissue construction. With the aim of developing a more efficient adipose tissue engineering technique based on DAT, in this study, we investigated the in vivo adipogenic potential of a basic fibroblast growth factor (bFGF) delivery system based on heparinized DAT (Hep-DAT). To generate this system, heparins were cross-linked to mouse DATs by using 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide and N-Hydroxysuccinimide. The bFGF-binding Hep-DATs were first tested for controlled release ability in vitro and then transplanted subcutaneously. Highly vascularized adipose tissues were formed 6 weeks after transplantation. Histology and gene expression analysis revealed that majority of the Hep-DAT scaffolds were infiltrated with host-derived adipose tissues that possessed similar adipogenic and inflammatory gene expression as endogenous adipose tissues. Additionally, strong de novo adipogenesis could also be induced when bFGF-binding Hep-DATs were thoroughly minced and injected subcutaneously. In conclusion, our study demonstrated that bFGF-binding Hep-DAT could be an efficient, biocompatible and injectable adipogenic system for in vivo adipose tissue engineering. © 2013 Elsevier Ltd. All rights reserved. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.jconrel.2013.11.007 | |
dc.source | Scopus | |
dc.subject | Adipose tissue engineering | |
dc.subject | ECM | |
dc.subject | Growth factors | |
dc.subject | Heparin | |
dc.type | Article | |
dc.contributor.department | DENTISTRY | |
dc.description.doi | 10.1016/j.jconrel.2013.11.007 | |
dc.description.sourcetitle | Journal of Controlled Release | |
dc.description.volume | 174 | |
dc.description.issue | 1 | |
dc.description.page | 43-50 | |
dc.description.coden | JCREE | |
dc.identifier.isiut | 000329964500006 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.